12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Tuesday's intraday session. Gainers included Delcath Systems, Novo Integrated Sciences, T2 Biosystems, Healthcare Triangle, Tiziana Life Sciences, and G Medical Innovations. Losers included Galecto, Design Therapeutics, Alaunos Therapeutics, Assure Hldgs, Bone Biologics, and OptimizeRx. Most of these movements were accompanied by unusually high trading volumes.
August 15, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Delcath Systems shares increased by 103.2% to $6.34 during Tuesday's regular session. The Q2 earnings report came out 4 days ago.
The significant increase in Delcath Systems' share price is likely due to the recent release of their Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
G Medical Innovations stock moved upwards by 18.06% to $0.21.
The significant increase in G Medical Innovations' share price is likely due to market dynamics.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Healthcare Triangle shares moved upwards by 28.24% to $4.54. The Q2 earnings report came out 3 days ago.
The significant increase in Healthcare Triangle's share price is likely due to the recent release of their Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Novo Integrated Sciences shares moved upwards by 54.86% to $0.11.
The significant increase in Novo Integrated Sciences' share price is likely due to market dynamics.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Tiziana Life Sciences stock rose 24.6% to $0.75.
The significant increase in Tiziana Life Sciences' share price is likely due to market dynamics.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
T2 Biosystems stock moved upwards by 41.0% to $0.55.
The significant increase in T2 Biosystems' share price is likely due to market dynamics.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Bone Biologics shares declined by 28.32% to $0.9.
The significant decrease in Bone Biologics' share price is likely due to market dynamics.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Design Therapeutics stock decreased by 69.28% to $2.25. Q2 earnings came out yesterday.
The significant decrease in Design Therapeutics' share price is likely due to the recent release of their Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Galecto stock decreased by 70.1% to $0.7.
The significant decrease in Galecto's share price is likely due to market dynamics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Assure Hldgs shares fell 49.42% to $0.31. The Q2 earnings report came out yesterday.
The significant decrease in Assure Hldgs' share price is likely due to the recent release of their Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
OptimizeRx shares declined by 27.37% to $9.13. Q2 earnings came out yesterday.
The significant decrease in OptimizeRx's share price is likely due to the recent release of their Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Alaunos Therapeutics shares decreased by 64.83% to $0.14. The Q2 earnings report came out yesterday.
The significant decrease in Alaunos Therapeutics' share price is likely due to the recent release of their Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100